LJM1R Stock Overview
Provides health care services in the Republic of Latvia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
AS Latvijas Juras medicinas centrs Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €6.95 |
| 52 Week High | €10.10 |
| 52 Week Low | €5.70 |
| Beta | -0.096 |
| 11 Month Change | -0.71% |
| 3 Month Change | 2.96% |
| 1 Year Change | -27.60% |
| 33 Year Change | -43.95% |
| 5 Year Change | 73.75% |
| Change since IPO | 4,350.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| LJM1R | LV Healthcare | LV Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | -27.6% | 0% | 0% |
Return vs Industry: LJM1R exceeded the LV Healthcare industry which returned -32.5% over the past year.
Return vs Market: LJM1R underperformed the LV Market which returned -11.7% over the past year.
Price Volatility
| LJM1R volatility | |
|---|---|
| LJM1R Average Weekly Movement | 8.1% |
| Healthcare Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in LV Market | 0% |
| 10% least volatile stocks in LV Market | 0% |
Stable Share Price: LJM1R's share price has been volatile over the past 3 months compared to the LV market.
Volatility Over Time: Insufficient data to determine LJM1R's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 366 | Janis Birks | www.ljmc.lv |
AS Latvijas Juras medicinas centrs provides health care services in the Republic of Latvia. The company engages in the general and special medical practice, dental practice, human health, residential nursing care, residential care, social work, physical well-being, and other personal service activities. It is also involved in provision of other education services related activities.
AS Latvijas Juras medicinas centrs Fundamentals Summary
| LJM1R fundamental statistics | |
|---|---|
| Market cap | €5.36m |
| Earnings (TTM) | -€760.42k |
| Revenue (TTM) | €10.20m |
0.5x
P/S Ratio-7.0x
P/E RatioIs LJM1R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LJM1R income statement (TTM) | |
|---|---|
| Revenue | €10.20m |
| Cost of Revenue | €9.69m |
| Gross Profit | €502.31k |
| Other Expenses | €1.26m |
| Earnings | -€760.42k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.95 |
| Gross Margin | 4.93% |
| Net Profit Margin | -7.46% |
| Debt/Equity Ratio | 0% |
How did LJM1R perform over the long term?
See historical performance and comparison